CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today